Search results
Showing 706 to 720 of 1559 results for do not do recommendations
Recommendation ID NG197/5 Question Shared decision making in remote discussions: How do shared decision-making skills and...
Recommendation ID PH41/4 Question What key factors ensure people continue to walk or cycle in the long term (over a year)? How...
Evidence-based recommendations on aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease in adults. This involves replacing the diseased part of the valve with some of the person’s own pericardium.
View recommendations for HTG689Show all sections
Caval valve implantation for tricuspid regurgitation (HTG726)
Evidence-based recommendations on caval valve implantation for tricuspid regurgitation in adults. This involves implanting valves into 1 or both caval veins without disturbing the tricuspid valve.
View recommendations for HTG726Show all sections
Recommendation ID NG209/09 Question E-cigarettes and established future smoking: Is e‑cigarette use in children, young people and young
Recommendation ID NG197/1 Question Differing intervention effects in different groups: How do the same shared...
Recommendation ID NG209/08 Question E-cigarette flavours: Do the flavours used in nicotine-containing e‑cigarettes have an...
Recommendation ID NG224/03 Question Symptoms and signs of recurrent UTI: Do the symptoms and signs of UTI in babies,...
This quality standard covers the routine antenatal care that women and their babies should receive during pregnancy. It describes high-quality care in priority areas for improvement.
View quality statements for QS22Show all sections
Sections for QS22
- Quality statements
- Quality statement 1: Access to antenatal care
- Quality statement 2: Risk assessment
- Quality statement 3: Continuity of carer
- Quality statement 4: Vaccination
- Quality statement 5: Referral for stop-smoking support and treatment
- Quality statement 6: Healthy eating in pregnancy
- Update information
Zanubrutinib for treating Waldenstrom's macroglobulinaemia (TA833)
Evidence-based recommendations on zanubrutinib (Brukinsa) for treating Waldenstrom’s macroglobulinaemia in adults.
Evidence-based recommendations on natalizumab originator (Tysabri) and biosimilar (Tyruko) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy in adults.
Recommendation ID NG102/4 Question Characteristics of a person delivering an intervention:- How do the professional...
Evidence-based recommendations on neratinib (Nerlynx) for extended adjuvant treatment of hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive early stage breast cancer in adults.
Evidence-based recommendations on icosapent ethyl (Vazkepa) with statin therapy for reducing the risk of cardiovascular events in adults with raised triglycerides.
Recommendation ID NG16/2 Question What are the most effective and cost-effective population-level measures to help people in mid-life...